Predictive Value of Cetuximab-Induced Skin Toxicity in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NECK

Overview of attention for article published in Frontiers in oncology, December 2018

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 27 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 17 publications that cite this research output.

17

The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.

Outcome Measurement Instruments Used to Evaluate Dermatologic Adverse Events in Cancer Trials

Article in JAMA Dermatology (March 2024)

Efficacy and safety of adapalene gel as a reactive treatment for cetuximab-induced skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck: A historical cohort comparison study

Article in Journal of Oncology Pharmacy Practice (April 2023)

Comparison of Second-Line Treatments for Patients with Platinum-Resistant Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Systematic Review and Bayesian Network Meta-Analysis

Article in Cancers (September 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.